Uniphar PLC
ISEQ:UPR
Relative Value
The Relative Value of one UPR stock under the Base Case scenario is hidden EUR. Compared to the current market price of 4.01 EUR, Uniphar PLC is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
UPR Competitors Multiples
Uniphar PLC Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IE |
U
|
Uniphar PLC
ISEQ:UPR
|
1B EUR | 0.4 | 15.7 | 11.3 | 15.8 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
117.1B USD | 0.3 | 29.1 | 20.4 | 23 | |
| US |
|
Cencora Inc
NYSE:COR
|
69.7B USD | 0.2 | 44.8 | 15.1 | 19.4 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.2B USD | 0.2 | 44.4 | 15 | 19.3 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53.9B USD | 0.2 | 32.4 | 15.6 | 20.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
36B AUD | 6 | 67.9 | 51.2 | 51.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
64.8B CNY | 1.5 | 17.5 | 13.5 | 13.5 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.1B CNY | 0.2 | 11.4 | 15.3 | 15.3 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.3B USD | 0.7 | 24.1 | 11.5 | 16.1 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.8B HKD | 0.1 | 8.6 | 1.6 | 2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |